These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3026294

  • 1. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study.
    Chalmers JP, Wing LM, West MJ, Bune AJ, Elliott JM, Morris MJ, Cain MD, Graham JR, Southgate DO.
    Aust N Z J Med; 1986 Aug; 16(4):475-80. PubMed ID: 3026294
    [Abstract] [Full Text] [Related]

  • 2. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.
    Wing LM, Chalmers JP, West MJ, Bune AJ, Russell AE, Elliott JM, Morris MJ.
    J Hypertens Suppl; 1987 Dec; 5(5):S603-6. PubMed ID: 2832575
    [Abstract] [Full Text] [Related]

  • 3. Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination.
    Wing LM, Chalmers JP, West MJ, Russell AE, Morris MJ, Cain MD, Bune AJ, Southgate DO.
    Clin Exp Hypertens A; 1988 Dec; 10(1):119-33. PubMed ID: 2832102
    [Abstract] [Full Text] [Related]

  • 4. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B, Herlitz H, Aurell M, Hansson L.
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension.
    Mehta J, Lopez LM, Thorman AD.
    Am J Cardiol; 1988 Apr 01; 61(10):803-6. PubMed ID: 2833090
    [Abstract] [Full Text] [Related]

  • 7. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr 01; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Apr 01; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE, Wu H, Boomsma F, van den Meiracker AH, Danser AH.
    Cardiovasc Drugs Ther; 2014 Aug 01; 28(4):335-45. PubMed ID: 24958603
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP, Bauer JH.
    J Clin Hypertens; 1986 Mar 01; 2(1):55-63. PubMed ID: 3014081
    [Abstract] [Full Text] [Related]

  • 11. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial.
    Sassano P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P, Ménard J.
    Am J Med; 1987 Aug 01; 83(2):227-35. PubMed ID: 3039842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Humoral effects of long-term oral enalapril therapy.
    Reams GP, Bauer JH.
    Am J Kidney Dis; 1986 May 01; 7(5):402-6. PubMed ID: 3010707
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G, Hertenberg F, Wetzels JF, Smits P.
    J Hypertens; 1998 Feb 01; 16(2):245-50. PubMed ID: 9535153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.